BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5069831)

  • 1. [Hypercalcemia and antithrombin activity in a case of IgA myeloma].
    Baele G; Lameire N
    Ned Tijdschr Geneeskd; 1972 Aug; 116(33):1444-50. PubMed ID: 5069831
    [No Abstract]   [Full Text] [Related]  

  • 2. [Visceral calcinosis induced by intravenous phosphate perfusions in myelomatous hypercalcemia].
    Deshayes P; Levillain D; Cauvin M; Forthomme J
    Sem Hop; 1969 Feb; 45(7):444-9. PubMed ID: 4307115
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined calcitonin and oral phosphate treatment for hypercalcemia in multiple myeloma.
    Brautbar N; Luboshitzky R
    Arch Intern Med; 1977 Jul; 137(7):914-6. PubMed ID: 879932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum multichannel autoanalyzers in the detection of hypercalcemia and hyperparathyroidism.
    Mays ET; Weakley SD
    Surg Gynecol Obstet; 1971 Oct; 133(4):603-8. PubMed ID: 5096308
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasmatic antithrombin activity in multiple myeloma].
    Nenci GG; Notaristefano A
    Boll Soc Ital Biol Sper; 1969 Nov; 45(22):1389-91. PubMed ID: 5398278
    [No Abstract]   [Full Text] [Related]  

  • 6. Phosphate supplementation as an adjunct in the therapy of multiple myeloma.
    Goldsmith RS; Bartos H; Hulley SB; Ingbar SH; Moloney WC
    Arch Intern Med; 1968 Aug; 122(2):128-33. PubMed ID: 4969948
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypercalcemia and electroencephalographic anomalies. Apropos of an observation of Kahler's disease with hypercalcemia].
    Manigand G; Delarue R; Foulon D; Deparis M
    Sem Hop; 1969 Jun; 45(29):2026-30. PubMed ID: 4308657
    [No Abstract]   [Full Text] [Related]  

  • 8. Inorganic phosphate treatment of hypercalcemia of diverse etiologies.
    Goldsmith RS; Ingbar SH
    N Engl J Med; 1966 Jan; 274(1):1-7. PubMed ID: 5901867
    [No Abstract]   [Full Text] [Related]  

  • 9. Gamma A myeloma in a dog with defective hemostasis.
    Shepard VJ; Dodds-Laffin WJ; Laffin RJ
    J Am Vet Med Assoc; 1972 Apr; 160(8):1121-7. PubMed ID: 5016941
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of multiple myeloma.
    Kyle RA; Maldonado JE; Bayrd ED
    Mayo Clin Proc; 1968 Oct; 43(10):730-7. PubMed ID: 5711940
    [No Abstract]   [Full Text] [Related]  

  • 11. [Polyvisceral metastatic calcinosis after inorganic phosphate perfusion for myelomatous acute hypercalcemia].
    Rapin M; Hirsch A; Bignon J; Marcel GA; Barois A
    J Urol Nephrol (Paris); 1970 Sep; 76(9):801-8. PubMed ID: 5482084
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood and neoplastic diseases. Myelomatosis.
    Malpas JS
    Br Med J; 1974 Nov; 4(5943):520-2. PubMed ID: 4434121
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes of the blood coagulation system in multiple myeloma].
    Alekseev NA; Klimova KN; Ushakova EA
    Probl Gematol Pereliv Krovi; 1967 Dec; 12(12):24-9. PubMed ID: 5616890
    [No Abstract]   [Full Text] [Related]  

  • 14. The current status and future prospects of treatment for multiple myeloma.
    Durie BG; Salmon SE
    Clin Haematol; 1982 Feb; 11(1):181-210. PubMed ID: 6176381
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary calcification in a patient with multiple myeloma.
    Fayemi AO; Wisniewski M
    Chest; 1973 Dec; 64(6):765-9. PubMed ID: 4760025
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of myelomatosis--M.R.C. trial.
    Galton DA
    Br Med J; 1971 May; 2(5757):323-4. PubMed ID: 4930211
    [No Abstract]   [Full Text] [Related]  

  • 17. Marked hypercalcemia in multiple myeloma.
    Zaroulis CG; Harkins MJ; Rosenblatt SD
    J Maine Med Assoc; 1967 Mar; 58(3):62-3. PubMed ID: 6039424
    [No Abstract]   [Full Text] [Related]  

  • 18. Secretion of parathyroid hormone-related peptide in patients with multiple myeloma.
    Beaudreuil J; Cohen-Solal M; Doré MX; Vernejoul MC; Bardin T; Celton N; Giraudeaux V; Kuntz D
    Rev Rhum Engl Ed; 1996; 63(7-8):502-3. PubMed ID: 8896065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prolonged activated partial thromboplastin time at diagnosis indicates less favorable prognosis in IgA myeloma.
    Teng HW; Chen PM; Yang YH; Gau JP
    Jpn J Clin Oncol; 2007 Aug; 37(8):609-14. PubMed ID: 17693643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral phosphates treatment of hypercalcemia in pregnancy.
    Levy HA; Pierucci L; Stroup P
    J Med Soc N J; 1981 Feb; 78(2):113-5. PubMed ID: 6938711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.